Mesenchymal Stem Cell Therapy for Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disease responsible for 60-70% of the 50 million cases of dementia worldwide. It is characterized by neuronal cell death, shrinkage of brain tissue, and progressive cognitive, motor, and behavioral impairment, which often leads to death. Although curre...
Main Authors: | A. E. Hernández, E. García |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2021/7834421 |
Similar Items
-
Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer’s disease
by: Mengtian Guo, et al.
Published: (2020-09-01) -
The therapeutic potential of mesenchymal stem cell in Alzheimer′s disease: converging mechanisms
by: Gadi Turgeman
Published: (2015-01-01) -
Mesenchymal stem cell therapy in heart disease
by: João Pedro Lopes, et al.
Published: (2013-01-01) -
Mesenchymal Stem Cell Therapy for rheumatic diseases
by: Yeung Winnie Wan-Yin, et al.
Published: (2016-08-01) -
Mesenchymal Stem Cell Therapy in Nonhematopoietic Diseases
by: Katherine Athayde Teixeira de Carvalho, et al.
Published: (2015-01-01)